Kalaris Therapeutics (KLRS) Enterprise Value (2020 - 2026)
Kalaris Therapeutics (KLRS) posted Enterprise Value of $3.39 million for Q2 2026, compared with -$38.49 million a year earlier and down 87.8% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Enterprise Value (2020 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics' Enterprise Value came in at $10.86 million.
- Annual Enterprise Value shows a five-year compound annual growth rate of -78.5% (FY2020 to FY2025).
- In prior years, Kalaris Therapeutics' Enterprise Value was -$69.92 million in FY2024, $1.6 billion in FY2023 (-81.8%), $8.81 billion in FY2022 (-52.8%) and $18.67 billion in FY2021 (-20.3%).
- Quarterly Enterprise Value has run from a low of -$69.92 million in Q4 2024 to a high of $36.14 billion in Q3 2021 over five years.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q3 2021, with growth of 43.3%; the weakest was Q3 2025, with a decline of 94.7%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $27.77 million (Q1 2026), $10.86 million (Q4 2025) and $108.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Kalaris Therapeutics | 67.84 Mn | 67.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Mn |
| Mar 31, 2026 | 27.77 Mn |
| Dec 31, 2025 | 10.86 Mn |
| Sep 30, 2025 | 108.02 Mn |
| Jun 30, 2025 | -38.49 Mn |
| Mar 31, 2025 | -68.42 Mn |
| Dec 31, 2024 | -69.92 Mn |
| Sep 30, 2024 | 2.03 Bn |
| Jun 30, 2024 | 1.79 Bn |
| Mar 31, 2024 | 1.85 Bn |
| Dec 31, 2023 | 1.60 Bn |
| Sep 30, 2023 | 5.42 Bn |
| Jun 30, 2023 | 7.15 Bn |
| Mar 31, 2023 | 8.26 Bn |
| Dec 31, 2022 | 8.81 Bn |
| Sep 30, 2022 | 16.55 Bn |
| Jun 30, 2022 | 5.64 Bn |
| Mar 31, 2022 | 9.78 Bn |
| Dec 31, 2021 | 18.67 Bn |
| Sep 30, 2021 | 36.14 Bn |
API Access
Kalaris Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();